| Literature DB >> 28972140 |
Lucy C Sullivan1, Nicholas G Walpole2, Carine Farenc2, Gabriella Pietra3,4, Matthew J W Sum1, Craig S Clements2, Eleanor J Lee1, Travis Beddoe2, Michela Falco5, Maria Cristina Mingari3,4,6, Lorenzo Moretta5, Stephanie Gras2,7, Jamie Rossjohn8,7,9, Andrew G Brooks10.
Abstract
αβ T cell receptors (TCRs) interact with peptides bound to the polymorphic major histocompatibility complex class Ia (MHC-Ia) and class II (MHC-II) molecules as well as the essentially monomorphic MHC class Ib (MHC-Ib) molecules. Although there is a large amount of information on how TCRs engage with MHC-Ia and MHC-II, our understanding of TCR/MHC-Ib interactions is very limited. Infection with cytomegalovirus (CMV) can elicit a CD8+ T cell response restricted by the human MHC-Ib molecule human leukocyte antigen (HLA)-E and specific for an epitope from UL40 (VMAPRTLIL), which is characterized by biased TRBV14 gene usage. Here we describe an HLA-E-restricted CD8+ T cell able to recognize an allotypic variant of the UL40 peptide with a modification at position 8 (P8) of the peptide (VMAPRTLVL) that uses the TRBV9 gene segment. We report the structures of a TRBV9+ TCR in complex with the HLA-E molecule presenting the two peptides. Our data revealed that the TRBV9+ TCR adopts a different docking mode and molecular footprint atop HLA-E when compared with the TRBV14+ TCR-HLA-E ternary complex. Additionally, despite their differing V gene segment usage and different docking mechanisms, mutational analyses showed that the TCRs shared a conserved energetic footprint on the HLA-E molecule, focused around the peptide-binding groove. Hence, we provide new insights into how monomorphic MHC molecules interact with T cells.Entities:
Keywords: T-cell receptor (TCR); major histocompatibility complex (MHC); mutagenesis; receptor structure-function; structural biology; viral immunology
Mesh:
Substances:
Year: 2017 PMID: 28972140 PMCID: PMC5743087 DOI: 10.1074/jbc.M117.807719
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157